Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients

YEN-HAO CHENYEN-YANG CHENJING-HOUNG WANGCHAO-HUNG HUNG2026-02-032026-02-032023-02-2810.21873/anticanres.16286https://scholars.csmu.edu.tw/handle/123456789/4721[SDGs]SDG3Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patientsjournal-article